DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Cao Y, Hunter ZR, Liu X. et al.
The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's macroglobulinemia.
Leukemia 2015;
29 (01) 169-176
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.